Hyun-Kyung Woo

Hyun-Kyung Woo

Auto-generated profile, based on publicly available information

Hyun-Kyung Woo

Center For Systems Biology Massachusetts General Hospital Research Institute Boston Massachusetts USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2018 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
HWHyun-Kyung Woo
Hyun-Kyung Woo
JPJuhee Park
Juhee Park
JKJa Yoon Ku
Ja Yoon Ku
CLChan Ho Lee
Chan Ho Lee
VSVijaya Sunkara
Vijaya Sunkara
YCYoon-Kyoung Cho
Yoon-Kyoung Cho
Detection of AR-V7 in urinary EVs provides a simple and promising liquid biopsy tool for patients with prostate cancer.

23 September 2022 in Science Advances
Verified
Journal Article
Open access
YCYoung Kwan Cho
Young Kwan Cho
HKHyunho Kim
Hyunho Kim
ABAlan BENARD
Alan BENARD
HWHyun-Kyung Woo
Hyun-Kyung Woo
FCFranziska Czubayko
Franziska Czubayko
HLHakho Lee
Hakho Lee
Electrochemiluminescence (ECL) has an inherently low background and enables precise chemical reactions through electrical control. Here, we report an advanced ECL system, termed ECLipse (ECL in paired signal electrode). We physically separated ECL generation from target detection: These two processes were carried out in isolated chambers and coupled through an electrode. The strategy allowed us to minimize cross-chemical reactions, design electrodes for high ECL signals, and integrate multiple sensors in a chip. As a proof of concept, we implemented an eight-plex ECLipse and applied it to detect host factors in human plasma. ECLipse achieved higher signal-to-noise ratio than conventional ECL assays and was >7000-fold more sensitive than enzyme-linked immunosorbent assay. In a pilot clinical study, we could detect septic conditions by measuring host factors [i.e., interleukin-3 (IL-3), IL-6, and procalcitonin (PCT)]. ECLipse assay further revealed distinct IL-3 and IL-6 patterns in patients with severe acute respiratory syndrome coronavirus 2 infection.

28 January 2026 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
HWHyun-Kyung Woo
Hyun-Kyung Woo
CKChanghyun Kim
Changhyun Kim
YCYoonjeong Choi
Yoonjeong Choi
YCYoung Kwan Cho
Young Kwan Cho
LDLuu-Ngoc Do
Luu-Ngoc Do
HLHakho Lee
Hakho Lee

28 January 2025 in Journal of Proteome Research
Verified
Journal Article
Closed access
HWHyun-Kyung Woo
Hyun-Kyung Woo
HAHee-Sung Ahn
Hee-Sung Ahn
JPJuhee Park
Juhee Park
JBJonghoon Bae
Jonghoon Bae
BKBokyung Kim
Bokyung Kim
YCYoon-Kyoung Cho
Yoon-Kyoung Cho

21 August 2025 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JJJueun Jeon
Jueun Jeon
QLQ. John Liu
Q. John Liu
HWHyunkyung Woo
Hyunkyung Woo
IBIsabel Barth
Isabel Barth
YCYoonjeong Choi
Yoonjeong Choi
HLHakho Lee
Hakho Lee

20 October 2021
Verified
Book Chapter
Closed access
PDF file
VSVijaya Sunkara
Vijaya Sunkara
HWHyun-Kyung Woo
Hyun-Kyung Woo
YCYoon-Kyoung Cho
Yoon-Kyoung Cho
Despite growing interest, there is still no method available for ideal extracellular vesicle (EV) separation with satisfactory yield, purity, and user-friendly operation. Enrichment and purification of EVs are complicated by the fact that EVs are intrinsically heterogeneous in their size, density, and cargo, which makes separation of pure fractions of EVs empirically impossible. Therefore, it is at the discretion of the user to make a strategy for EV separation depending on the sample type, volume, and their downstream applications. Here, basic guidelines are provided to select a method for each type of biofluid, rating each method's performance in terms of total processing time, ease of use, feasible sample volume, yield, and purity of the concentrated EVs. The emerging technologies to achieve pure EVs and to unveil their heterogeneity are outlined together with the remaining challenges that need to be overcome.